The economic gains of achieving reduced alcohol consumption targets for Australia

American Journal of Public Health

Volumn 102, Issue 7, 2012, Pages 1313-1319

  Magnus, Anne ^a   Cadilhac, Dominique ^a   Sheppard, Lauren ^a   Cumming, Toby ^a   Pearce, Dora ^b   Carter, Rob ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; AUSTRALIA; COST OF ILLNESS; DRINKING BEHAVIOR; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; STATISTICS;

ABSENTEEISM; ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; AUSTRALIA; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84862882506     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300453     Document Type: Review

References (33)

1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden ofdisease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682): 2223-2233.
2. Balakrishnan R, Allender S, Scarborough P, Webster P, Rayner M. The burden of alcohol-related ill health in the United Kingdom.J Public Health (Oxf). 2009;31(3): 366-373.
3. Australian Alcohol Guidelines: Health Risks and Benefits. Canberra, Australia: National Health and Med-ical Research Council; 2001.
4. OECD Health Data. Paris, France: Organization for Economic Cooperation and Development; 2008. Avail-able at: http://www.oecd.org/document/16/0, 3343, en-2649-34631-2085200-1-1-1-1,00.html. Accessed July 9, 2008.
5. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez AD. The Burden of Disease and Injury in Australia 2003. Vol PHE 82. Canberra, Australia: Australian Institute of Health and Welfare; 2007:337.
6. Jackson R, Broad J, Connor J, Wells S. Alcohol and ischaemic heart disease: probably no free lunch. Lancet. 2005;366(9501):1911-1912. (Pubitemid 41713977)
7. Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies. Ann Epide-miol. 2007;17(5, suppl):S16-S23. (Pubitemid 46671514)
8. Australian Drug Foundation. Blood alcohol con-centration. 2011. Available at: http://www.druginfo.adf. org.au/topics/bac Accessed January 31, 2011.
9. Ministerial Council on Drug Strategy. National Alcohol Strategy 2006-201 1. Canberra, Australia: Commonwealth of Australia; 2006.
10. Drummond A, Sullivan G, Cavallo A An Evaluation ofthe Random Breath Testing Initiative in Victoria 1989-1990. Quasi-experimental Time Series Approach. Mel-bourne, Australia: Monash University Accident Research Centre; 1992.
11. Australia: The Healthiest Country by 2020. National Preventative Health Strategy-The Roadmap for Action. Canberra, Australia: National Preventative Health Task-force; 2009.
12. Bhattacharya J, Lakdawalla DN. The labor market value of health improvements. Forum Health Econ Policy. 2006;9(2 [Biomedical Research and the Economy]): article 2.
13. Collins DJ, Lapsley HM. The costs oftobacco, alcohol and illicit drug abuse to Australian Society in 2004/05. Canberra, Australia: Department of Health and Ageing; 2008. Monograph series no. 64.
14. Magnus A, Cadilhac D, Sheppard L, Cumming TB, Pearce D, Carter R. The economic gains of realistic smoking cessation targets for Australia. Am J Public Health. 2011(2);101:321-327.
15. Cadilhac DA, Magnus A, Sheppard L, Cumming TB, Pearce DC, Carter R. The societal benefits of reducing six behavioural risk factors: An economic modelling study from Australia. BMC Public Health 2011;11:483.
16. Cadilhac DA, Cumming TB, Sheppard L, Pearce DC, Carter R, Magnus A The economic benefits of reducing physical inactivity: An Australian example. Int J Behav Nutr Phys Act. 2011;8:99.
17. Armstrong B. Morbidity and mortality in Australia: how much is preventable? In: Mc Neil JJ, King RWF, Jennings GL, Powles J, eds. A Textbook of Preventive Medicine. Melbourne, Australia: Edward Arnold; 1990.
18. Brand DA, Saisana M, Rynn LA, Pennoni F, Lowenfels AB. Comparative analysis of alcohol control policies in 30 countries. PLo SMed. 2007;4(4):e151.
19. Health System Expenditure on Disease and Injury in Australia, 2000-01. Canberra, Australia: Australian Institute of Health and Welfare; 2004.
20. Public Health Expenditure in Australia, 2006-07. Canberra, Australian Capital Territory, Australia: Aus-tralian Institute of Health and Welfare; 2008.
21. National Health Survey (2004-05). Basic and expanded CURF data. Findings based on use of ABS CURF data, CD-ROM and RADL. Canberra, Australia: Australian Bureau of Statistics; 2006.
22. How Australians Use Their Time, 2006. Canberra Australia: Australian Bureau of Statistics; 2008.
23. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
24. Koopmanschap MA, Rutten FF. A practical guide for calculating indirect costs of disease. Pharmacoeconomics. 1996;10(5):460-466. (Pubitemid 26359874)
25. Liljas B. How to calculate indirect costs in economic evaluations. Pharmacoeconomics. 1998;13(1 pt 1):1-7.
26. Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation litera-ture: areview. Int J Technol Assess Health Care. 1998;14 (4):799-808. (Pubitemid 29029307)
27. Cadilhac D, Magnus A, Cumming T, Sheppard L, Pearce D, Carter R. The Economic Benefits of Reducing Disease Risk Factors. Melbourne, Australia: Deakin Health Economics Group, Deakin University and Na-tional Stroke Research Institute; 2009.
28. Vos T, Carter R, Barendregt J, et al. Assessing Cost-Effectiveness in Prevention (ACE-Prevention): Final Report. Melbourne, Australia: University of Queensland, Bris-bane, and Deakin University; 2010.
29. Rehm J, Taylor B, Patra J, Gmel G. Avoidable burden ofdisease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res. 2006; 15(4):181-191. (Pubitemid 47047026)
30. Fenoglio P, Parel V, Kopp P. The social cost of alcohol, tobacco and illicit drugs in France, 1997. Eur Addict Res. 2003;9(1):18-28. (Pubitemid 36160293)
31. Varney SJ, Guest JF. The annual societal cost of alcohol misuse in Scotland. Pharmacoeconomics. 2002; 20(13):891-907. (Pubitemid 35252840)
32. Rehm J, Gnam W, Popova S, et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002 (report). J Stud Alcohol Drugs. 2007;68(6):886-895. (Pubitemid 350144498)
33. Harwood H. Updating Estimates ofthe Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2000.